PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
24.72%
Positive revenue growth while 9698.HK is negative. John Neff might see a notable competitive edge here.
-76.02%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-56.61%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-38.79%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-32.02%
Negative net income growth while 9698.HK stands at 2278.07%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-32.52%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-32.52%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.00%
Share reduction more than 1.5x 9698.HK's 179.52%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.00%
OCF growth above 1.5x 9698.HK's 44.86%. David Dodd would confirm a clear edge in underlying cash generation.
100.00%
FCF growth 75-90% of 9698.HK's 124.27%. Bill Ackman might push for improved capital allocation or operational changes to match the competitor.
-94.79%
Negative 10Y revenue/share CAGR while 9698.HK stands at 292.15%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-72.16%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-8.24%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-100.00%
Negative 10Y OCF/share CAGR while 9698.HK stands at 994.25%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-100.00%
Negative 5Y OCF/share CAGR while 9698.HK is at 256.87%. Joel Greenblatt would question the firm’s operational model or cost structure.
100.00%
Positive 3Y OCF/share CAGR while 9698.HK is negative. John Neff might see a big short-term edge in operational efficiency.
-312.21%
Negative 10Y net income/share CAGR while 9698.HK is at 4631.17%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-557.81%
Negative 5Y net income/share CAGR while 9698.HK is 1219.15%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
20.57%
Below 50% of 9698.HK's 569.22%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
-55.77%
Negative equity/share CAGR over 10 years while 9698.HK stands at 249.10%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-54.84%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-48.30%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-52.48%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
-13.61%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-13.92%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-34.53%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
97.32%
We increase R&D while 9698.HK cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
3.37%
We expand SG&A while 9698.HK cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.